• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Dr. McLeod becomes chairman of ophthalmology at UCSF

Article

Stephen D. McLeod, MD, is the new chairman of the Department of Ophthalmology at the University of California, San Francisco (UCSF).

Stephen D. McLeod, MD, is the new chairman of the Department of Ophthalmology at the University of California, San Francisco (UCSF).

Dr. McLeod joined the UCSF faculty in 1998 and had been serving as interim chairman of the ophthalmology department since January. In 2006, the program was rated 10th in the country by U.S. News and World Report.

Dr. McLeod's research bridges the areas of cornea and external diseases, cataract, and refractive surgery, and includes the diagnosis and management of infectious keratitis, the development of materials for the artificial cornea (keratoprosthesis), and the development of IOLs that restore accommodation or dynamic change in focus after cataract surgery.

He has published extensively in these areas and has served as a consultant to the FDA ophthalmic devices panel. Dr. McLeod is the co-editor of the online edition of the Archives of Ophthalmology and serves on the editorial board of the Journal of Refractive Surgery.

He has served the American Academy of Ophthalmology in several capacities and currently is chairman of the Preferred Practice Patterns Refractive Surgery Panel.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.